Unusual MHC-like molecules: CD1, Fc receptor, the hemochromatosis gene product, and viral homologs

Current Opinion in Immunology

Volumn 10, Issue 1, 1998, Pages 67-73

  Wilson, Ian A ^a   Bjorkman, Pamela J ^b  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b CALIFORNIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD1 ANTIGEN; FC RECEPTOR; IMMUNOGLOBULIN; IRON; LIPID; MAJOR HISTOCOMPATIBILITY ANTIGEN; T LYMPHOCYTE RECEPTOR;

ANTIGEN PRESENTATION; CRYSTAL STRUCTURE; HEMOCHROMATOSIS; HUMAN; IMMUNE SYSTEM; IRON METABOLISM; NATURAL KILLER CELL; NONHUMAN; PROTEIN FOLDING; REVIEW; T LYMPHOCYTE; VIRUS PARTICLE;

EID: 0032006992     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(98)80034-4     Document Type: Article

References (65)

1. Bjorkman PJ, Saper MA, Samraoui B, Bennett WS, Strominger JL, Wiley DC. Structure of the human class I histocompatibility antigen, HLA-A2. Nature. 329:1987;506-512.
2. Bjorkman PJ, Saper MA, Samraoui B, Bennett WS, Strominger JL, Wiley DC. The foreign antigen binding site and T cell recognition regions of class I histocompatibiity antigens. Nature. 329:1987;512-518.
3. Madden DR, Garboczi DN, Wiley DC. The antigenic identity of peptide-MHC complexes: a comparison of the conformations of five viral peptides presented by HLA-A2. Cell. 75:1993;693-708.
4. b. Science. 257:1992;919-927.
5. Madden D. The three-dimensional structure of peptide-MHC complexes. Annu Rev Immunol. 13:1995;587-622.
6. Stem LJ, Brown JH, Jardetzky TS, Gorga JC, Urban RG, Strominger JL, Wiley DC. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature. 368:1994;215-221.
7. Fremont DH, Hendrickson WA, Marrack P, Kappler J. Structures of an MHC class II molecule with covalently bound single peptides. Science. 272:1996;1001-1004.
8. Stern LJ, Wiley DC. Antigenic peptide binding by class I and class II histocompatibility proteins. Structure. 2:1994;245-251.
9. Wilson IA. Another twist to MHC-peptide recognition. Science. 272:1996;973-974.
10. Rammensee HG, Friede T, Stevanoviic S. MHC ligands and peptide motifs: first listing. Immunogenetics. 41:1995;178-228.
11. Garboczi DN, Ghosh P, Utz U, Fan QR, Biddison WE, Wiley DC. Structure of the complex between human T-cell receptor, viral peptide and HLA-A2. Nature. 384:1996;134-141.
12. Garcia KC, Degano M, Stanfield RL, Brunmark A, Jackson MR, Peterson PA, Teyton L, Wilson IA. An αβ T-cell receptor structure at 2.5åA and its orientation in the TCR-MHC complex. Science. 274:1996;209-219.
13. Bjorkman PJ. MHC restriction in three dimensions: A view of T cell receptor/ligand interactions. Cell. 89:1997;167-170.
14. Wang CR, Castano AR, Peterson PA, Slaughter C, Lindahl KF, Deisenhofer J. Nonclassical binding of formylated peptide in crystal structure of the MHC class lb molecule H2-M3. Cell. 82:1995;654-664.
15. Burmeister WP, Gastinel LN, Simister NE, Blum ML, Bjorkman PJ. Crystal structure at 2.2Å resolution of the MHC-related neonatal Fc receptor. Nature. 372:1994;336-343.
16. Burmeister WP, Huber AH, Bjorkman PJ. Crystal structure of the complex of rat neonatal FC receptor with Fc. Nature. 372:1994;379-383.
17. Davies DR, Padlan EA, Sheriff S. Antibody-antigen complexes. Annu Rev Biochem. 59:1990;439-473.
18. Wells JA, de Vos AM. Hematopoietic receptor complexes. Annu Rev Biochem. 65:1996;609-634.
19. Deisenhofer J. Crystallographic refinement and atomic models of a human Fc fragment and its complex with fragment B of protein A from staphylococcus aureus at 2.9Å Biochemistry. 20:1981;2361-2370.
20. Sauer-Eriksson AE, Kleywegt GJ, Uhlen M, Jones TA. Crystal structure of the C2 fragment of streptococcal protein G in complex with the Fc domain of human IgG. Structure. 3:1995;265-278.
21. Derrick JP, Wigley DB. The third IgG-binding domain from streptococcal protein G. An analysis by X-ray crystallography of the structure alone and in a complex with Fab. J Mol Biol. 243:1994;906-918.
22. Corper AL, Sohi MK, Bonagura VR, Steinitz M, Jefferis R, Feinstein A, Beale D, Taussig MJ, Sutton BJ. Structure of human IgM rheumatoid factor Fab bound to its autoantigen IgG Fc reveals a novel topology of antibody-antigen interaction. Nat Struct Biol. 4:1997;374-381.
23. Kuehn MJ, Ogg DJ, Kihlberg J, Slonim LN, Flemmer K, Bergfors T, Hultgren SJ. Structural basis of pilus subunit recognition by the PapD chaperone. Science. 262:1993;1234-1241.
24. Gao GF, Tormo J, Gerth UC, Wyer JR, McMichael AJ, Stuart DI, Bell JI, Jones EY, Jakobsen BK. Crystal structure of the complex between human CD8αα and HLA-A2. Nature. 387:1997;630-634.
25. Jardetzky TS, Brown JH, Gorga JC, Stern LJ, Urban RG, Chi YI, Stauffacher C, Strominger JL, Wiley DC. Three-dimensional structure of a human class II histocompatibility molecule complexed with superantigen. Nature. 368:1994;711-718.
26. McMichael AJ, Pilch JR, Galfre G, Mason DY, Fabre JW, Milstein C. A human thymocyte antigen defined by a hybrid myeloma monoclonal antibody. J Immunol. 9:1979;205-210.
27. Porcelli SA. The CD1 family: a third lineage of antigen-presenting molecules. J Immunol. 59:1995;1-98.
28. Beckman EM, Porcelli SA, Morita CT, Behar SM, Furlong ST, Brenner MB. Recognition of a lipid antigen by CD1-restricted (αβ+) T cells. Nature. 372:1994;691-694.
29. Sieling PA, Chatterjee D, Porcelli SA, Prigozy TI, Mazzaccaro RJ, Soriano T, Bloom BR, Brenner MB, Kronenberg M, Brennan PJ, Modlin RL. CD1-restricted T cell recognition of microbial lipoglycan antigens. Science. 269:1995;227-230.
30. Bendelac A. CD1: Presenting unusual antigens to unusual T lymphocytes. Science. 269:1995;185.
31. Beckman EM, Melian A, Behar SM, Sieling PA, Chatterjee D, Furlong ST, Matsumoto R, Rosat JP, Modlin RL, Porcelli SA. CD1c restricts reponses of mycobacteria-specific T cells. Evidence for antigen presentation by a second member of the human CD1 family. of special interest J Immunol. 157:1996;2795-2803 Another member of the CD1 family is now shown to give rise to an antigen-specific T cell response. This supports the idea that CD1 molecules present novel lipid antigens to T cells.
32. Moody DB, Reinhold BB, Guy MR, Beckman EM, Frederique DE, Furlong ST, Ye S, Reinhold VN, Sieling PA, Modlin RL, et al. Structural requirements for glycolipid antigen recognition by CD1b-restricted T cells. of outstanding interest Science. 278:1997;283-286 This shows that human CD1b can also interact with mycobacterial glucose monomycolate. Its presentation to CD1b-restricted T cells is extremely sensitive to the carbohydrate and polar substituents and not to the lipid tails. Thus, the inference is that T-cell receptors specifically recognize the hydrophobic components of the bound glycolipids, whereas the CD1b molecules bind relatively nonspecifically to the lipid acyl tails.
33. Sugita M, Jackman RM, van Donselaar E, Behar SM, Roger RA, Peters PJ, Brenner MB, Porcelli SA. Cytoplasmic tail-dependent localization of CD1b antigen-presenting molecules to MIICs. Science. 273:1996;349-352.
34. Prigozy TI, Sieling PA, Clemens D, Stewart PL, Behar SM, Porcelli SA, Brenner MB, Modlin RL, Kronenberg M. The mannose receptor delivers lipoglycan antigens to endosomes for presentation to T cells by CD1b molecules. of outstanding interest Immunity. 6:1997;187-197 Glycolipid antigens such as lipoarabinomannans are taken up by the mannose receptor and allow co-localization of lipid antigens with CD1b molecules in late endosomes, lysosomes and endosoma-like compartments that contain MHC class II molecules (MIICs). This pathway explains how lipids from microbial pathogens can be transferred and loaded on to CD1 molecules and provides a link from the innate immune response to the adaptive immune response.
35. Zeng ZH, Castano AR, Segelke B, Stura EA, Peterson PA, Wilson IA. The crystal structure of murine CD1: an MHC-like fold with a large hydrophobic binding groove. of outstanding interest Science. 277:1997;339-345 This describes how murine CD1d1 structure shows a close relationship with MHC class I molecules. The predominantly hydrophobic binding groove explains the preference of CD1 molecules for hydrophobic antigens, particularly lipids and glycolipids, in preference to peptide antigens presented by MHC class I and class II molecules.
36. Beamer LJ, Carroll SF, Eisenberg D. Crystal structure of human BPI and two bound phospholipids at 2.4 angstrom resolution. of outstanding interest Science. 276:1997;1861-1854 This shows that a phosphatidylcholine molecule is bound by the bactericidal/permeability-increasing protein predominantly by interaction of the acyl chains with the protein. This structure provides an excellent model for how lipopolysaccharides can bind to proteins with the lipid acyl chains inside and the carbohydrate moieties outside, similar to the mechanism proposed for lipid binding to CD1 in [35].
37. Castano AR, Tangri S, Miller JEW, Holcombe HR, Jackson MR, Huse WD, Kronenberg M, Peterson PA. Peptide binding and presentation by mouse CD1. Science. 269:1995;223-226.
38. + T cells. The tyrosine-based motif in the cytoplasmic tail that targets CD1 to endosomal compartments is not required for recognition by this T cell population. Hence, the authors suggest that recognition either may not involve a specific antigen or may be through a conserved antigen acquired from a non-endocytic compartment.
39. + T cells in major histocompatibility complex class II-deficient mice. J Exp Med. 182:1995;993-1004.
40. Bendelac A. Mouse NK1+ T cells. Curr Opin Immunol. 7:1995;367-374.
41. + T cells are also found. These results strengthen the argument for an important antigen-presenting function for CD1 in the host immune system.
42. Cheroutre H, Holcombe HR, Tangri S, Castano AR, Teitell M, Miller JE, Cardell S, Benoist C, Mathis D, Huse WD, et al. Antigen-presenting function of the TL antigen and mouse CD1 molecules. Immunol Rev. 147:1995;31-52.
43. Porcelli SA, Morita CT, Modlin RL. T-cell recognition of non-peptide antigens. Curr Opin Immunol. 8:1996;510-516.
44. Maher JK, Kronenberg M. The role of CD1 molecules in immune responses to infection. Curr Opin Immunol. 9:1997;456-461.
45. Blumberg RS, Colgan SP, Balk SP. CD1d: outside-in antigen presentation in the intestinal epithelium? Clin Exp Immunol. 109:1997;223-225.
46. Jullien D, Stenger S, Ernst WA, Modlin RL. CD1 presentation of microbial nonpeptide antigens to T cells. J Clin Invest. 99:1997;2071-2074.
47. Junghans RP. Finally! The Brambell receptor (FcRB). Mediator of transmission of immunity and protection from catabolism for IgG. of special interest Immunol Res. 16:1997;29-57 A comprehensive review with a historical perspective that summarizes the work demonstrating that the rat neonatal Fc receptor functions as the catabolic receptor for IgG, as well as for transfer of IgG from mother to newborn.
48. Simister NE, Mostov KE. An Fc receptor structurally related to MHC class I antigens. Nature. 337:1989;184-187.
49. Vaughn DE, Milburn CM, Penny DM, Martin WL, Johnson JL, Bjorkman PJ. Identification of critical IgG binding epitopes on the neonatal Fc receptor. J Mol Biol. 274:1997;597-607.
50. Raghavan M, Chen MY, Gastinel LN, Bjorkman PJ. Investigation of the interaction between the class I MHC-related Fc receptor and its immunoglobulin G ligand. Immunity. 1:1994;303-315.
51. Raghavan M, Wang Y, Bjorkman PJ. Effects of receptor dimerization on the interaction between the class I MHC related Fc receptor and immunoglobulin G. Proc Natl Acad Sci USA. 92:1995;11200-11204.
52. Vaughn DE, Bjorkman PJ. Structural basis of pH dependent antibody binding by the neonatal Fc receptor. Structure. 6:1998;63-73.
53. Ghetie V, Popov S, Borvak J, Radu C, Matesoi D, Medesan C, Ober RJ, Ward ES. Increasing the serum persistence of an IgG fragment by random mutagenesis. of outstanding interest Nat Biotechnol. 15:1997;637-640 Random mutagenesis of a portion of Fc that contacts the rat neonatal Fc receptor (FcRn) was used to find an Fc mutant that binds more tightly to FcRn and has a longer half-life in serum.
54. Junghans RP. Next generation Fc chimeric proteins: avoiding immune system interactions. Trends Biotechnol. 15:1997;155.
55. Raghavan M, Bjorkman PJ. Fc receptors and their interactions with immunoglobulins. Annu Rev Cell Dev Biol. 12:1996;181-220.
56. Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, Dormishian F, Domingo R Jr, Ellis MC, Fullan A, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. of outstanding interest Nat Genet. 13:1996;399-408 Report of the positional cloning of the hereditary hemochromatosis gene product, formerly known as HLA-H, since renamed HFE. The finding that the gene resembles class I MHC genes correlates with previous work (see references within paper) in wich β2 microglobulin deficient mice were observed to develop iron overload.
57. Feder JN, Tsuchihashi Z, Irrinki A, Lee VK, Mapa FA, Morikang E, Prass CE, Starnes SM, Wolff RK, Parkkila S, et al. The hemochromatosis founder mutation in HLA-H disrupts β2-microglobulin interaction and cell surface expresssion. J Biol Chem. 272:1997;14025-14028.
58. Lanier LL, Corliss B, Phillips JH. Arousal and inhibition of human NK cells. Immunol Rev. 155:1997;145-154.
59. Beck S, Barrell BG. Human cytomegalovirus encodes a glycoprotein homologous to MHC class-I antigens. Nature. 331:1988;269-272.
60. Rawlinson WD, Farrell HE, Barrell BG. Analysis of the complete DNA sequence of murine cytomegalovirus. J Virol. 70:1996;8833-8849.
61. Farrell HE, Vally H, Lynch DM, Fleming P, Shellam GR, Scalzo AA, Davis-Poynter NJ. Inhibition of natural killer cells by a cytomegalovirus MHC class I homologue in vivo. of outstanding interest Nature. 386:1997;510-514 The authors compare the immune responses of mice infected with either wild-type murine cytomegalovirus or a recombinant m144-deletion virus, finding that antiviral natural killer cell responses are more effective in the absence of m144.
62. Fahnestock ML, Johnson JL, Feldman RMR, Neveu JM, Lane WS, Bjorkman PL. The MHC class I homolog encoded by human cytomegalovirus binds endogenous peptides. Immunity. 3:1995;583-590.
63. Reyburn HT, Mandelboim O, Vales-Gomez M, Davis DM, Pazmany L, Strominger JL. The class I MHC homologue of human cytomegalovirus inhibits attack by natural killer cells. of outstanding interest Nature. 386:1997;514-517 The authors report that a class I negative cell line transfected with the UL18 gene (which encodes an MHC class I heavy chain homolog) inhibits natural killer cells through their CD94 lectin-like receptor. This result is called into question by the inability of other laboratories to detect cell surface expression of UL18 when its gene is transfected into the same cell line (CC Leong et al., unpublished data), and by the identification to the UL18 cellular receptor as LIR-1 [64], a protein expressed primarily on B cells and monocytes.
64. Cosman D, Fanger N, Borges L, Kubin M, Chin W, Peterson L, Hsu M-L. A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules. of outstanding interest Immunity. 7:1997;273-282 A UL18-Fc fusion protein is used to find the cellular receptor for UL18. The receptor was identified as LIR-1, a newly discovered member of the immunoglobulin gene superfamily. LIR-1 shows homology to human natural killer cell receptors, but is primarily expressed on B cells and monocytes rather than on natural killer cells.
65. Chapman TL, Bjorkman PJ. Characterization of a murine cytomegalovirus class I MHC homolog: Comparison to MHC molecules and to the human cytomegalovirus MHC homolog. J Virol. 72:1998;460-466.